DKC1 and breast carcinoma: They identified four molecules (compound 1, 5, 6, and 10) that significantly inhibited dyskerin pseudouridylation activity, among which only compound 1 (pyrazofurin) showed a significant cytotoxic activity in MCF7 breast cancer cells (Fig. 7c) [473].